Suzhou, China

Haikuo Ma

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Haikuo Ma: Innovator in CXCR4 Pathway Therapeutics**

Introduction

Haikuo Ma is a prominent inventor based in Suzhou, China, known for his contributions to pharmaceutical innovations. With an impressive portfolio of three patents, he focuses on the development of heteroaryl compounds that target critical biological pathways, specifically concerning diseases linked to the CXCR4 pathway and necrosis.

Latest Patents

Haikuo Ma's latest inventions highlight his expertise in medicinal chemistry. One of his notable patents, titled “Heteroaryl Compounds as CXCR4 Inhibitors, Composition and Method Using the Same,” presents a novel class of heteroaryl compounds designed to inhibit the CXCR4 pathway. This patent discusses the synthesis of these compounds, pharmaceutical formulations, and their potential application in treating various diseases and disorders.

Another significant patent is “Heteroaryl Compounds as Inhibitors of Necrosis, Composition and Method Using the Same.” This invention shares a similar framework, detailing heteroaryl compounds aimed at treating conditions related to necrosis. The disclosures in both patents include detailed methodologies for the compounds’ preparation and their therapeutic applications.

Career Highlights

Haikuo Ma has collaborated with notable companies such as Cgenetech (Suzhou, China) Co., Ltd. and Accro Bioscience (HK) Limited. His work in these organizations has facilitated significant advancements in pharmaceutical research and development, particularly in creating innovative therapeutic agents that address unmet medical needs.

Collaborations

Throughout his career, Haikuo Ma has worked alongside talented professionals, including Xiaohu Zhang and Jiyue Zheng. These collaborations have fostered a dynamic research environment, enhancing the development of cutting-edge innovations in the field of drug discovery.

Conclusion

In conclusion, Haikuo Ma's contributions to the field of pharmaceutical sciences exemplify the impact of innovation in healthcare. His patents embody his commitment to developing advanced therapeutic solutions for complex medical challenges. As he continues his work, Haikuo Ma remains a key figure in the quest for effective treatments targeting the CXCR4 pathway and necrosis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…